Qualcomm Institute-based Startup Receives Funding to Continue Development of Opioid Sensor

CARI Therapeutics has received additional funding from the National Institute of Drug Abuse to refine their tiny implantable biosensor that could help combat the deadly and destructive opioid crisis in the United States.

Click to view original post

Advertise With Us